bupropion

(redirected from bupropion hydrochloride)
Also found in: Dictionary.

bupropion

 [bu-pro´pe-on]
a compound structurally similar to amphetamine, used in the form of the hydrochloride salt as an antidepressant and as an aid in smoking cessation to reduce the symptoms of nicotine withdrawal; administered orally.

bupropion

/bu·pro·pi·on/ (bu-pro´pe-on) a monocyclic compound structurally similar to amphetamine, used as the hydrochloride salt as an antidepressant and as an aid in smoking cessation.

bupropion

(byo͞o-prō′pē-ŏn′)
n.
A drug, C13H18ClNO, used in its hydrochloride form for the treatment of depression and as an aid in smoking cessation. It is a weak inhibitor of norepinephrine and dopamine reuptake in the central nervous system.

buPROPion

[boo͡prō′pē·on]
a heterocyclic mood-elevating drug used to treat some types of depression (trademark: Wellbutrin) and also to promote smoking cessation (trademark: Zyban).

bupropion

Zyban® Psychiatry An antidepressant Side effects Dry mouth, insomnia Contraindications Seizures, bulimia

bupropion

A drug used in the treatment of tobacco, drug and alcohol dependency. Bupropion reacts adversely with a wide range of other drugs and may induce seizures in sensitive persons. When used, a strict regime is necessary. A brand name is Zyban.

Bupropion

An antidepressant medication given to smokers for nicotine withdrawal symptoms. It is sold under the trade name Zyban.

bupropion (byōō´prō´pēon),

n brand names: Wellbutrin, Zyban;
drug class: antidepressant;
action: weak uptake inhibitor of dopamine, serotonin, norepinephrine; mechanism unknown;
uses: treatment of depression and anxiety disorders; tobacco cessation.
References in periodicals archive ?
Jubilant Pharma Ltd, a subsidiary of India-based pharmaceutical firm Jubilant Life Sciences (NSE: JUBILANT), has received final approval from the US health regulator for Bupropion Hydrochloride Extended-Release Tablets, a BSE filing by the company revealed on Thursday.
Sun Pharma (NSE: SUNPHARMA), an Indian multinational pharmaceutical company, has issued a voluntary recall of an anti-depressant drug known as Bupropion Hydrochloride, it emerged on Wednesday.
Of the 38 states that offered at least one form of coverage to all Medicaid beneficiaries in 2005, all covered some type of medication treatment, including generic bupropion hydrochloride or Zyban[R]* (36 states), nicotine nasal sprays (28 states), nicotine inhalers (28 states), nicotine patches (33 states), and nicotine gum (31 states).
Bupropion Hydrochloride (SR) Extended Release tablets are indicated for the treatment of major depressive disorder.
Pharmaceutical company Mylan Inc (NasdaqGS:MYL) reported on Thursday the receipt of approval from the US Food and Drug Administration (FDA) for its supplemental Abbreviated New Drug Application (sANDA) with bioequivalence study results for Bupropion Hydrochloride (HCl) Extended-release (ER) Tablets USP (XL), 300 mg.
Upon the deal's closing, Sandoz picked up Actavis' diltiazem hydrochloride extended-release capsules (Tiazac), lorazepam tablets (Ativan) and bupropion hydrochloride extended-release tablets (Zyban).
The antidepressant bupropion hydrochloride does not significantly increase longer-term smoking cessation rates for some patients, despite several recent studies touting its use for this purpose, Dr.
According to Teva, the trial is intended to address reports of inefficacy and adverse events by consumers who switched from Wellbutrin XL([R])300 mg, Biovail's FDA-approved brand of the antidepressant, bupropion hydrochloride, to Budeprion XL, Teva's generic formulation of the drug.
M2 EQUITYBITES-August 23, 2013-Mylan Inc wins FDA approval of sANDA for Bupropion Hydrochloride Extended-Release Tablets USP (XL) 300 mg(C)2013 M2 COMMUNICATIONS http://www.
Mylan has also announced the launch of bupropion hydrochloride extended-release tablets USP (XL), 150 mg and 300 mg (once daily), the generic version of GlaxoSmithKline PLC's antidepressant Wellbutrin XL.
1 October 2010 - US generic and specialty pharmaceutical company Mylan Inc (NASDAQ: MYL) said today that its subsidiary Mylan Pharmaceuticals Inc has launched Bupropion Hydrochloride Extended-release Tablets USP, (XL), 150 mg and 300 mg (Once-Daily), the generic version of GlaxoSmithKline's (LON: GSK) antidepressant Wellbutrin XL.
Specialist pharmaceutical company Mylan Inc (Nasdaq:MYL) stated on Friday that the company has introduced Bupropion Hydrochloride Extended-release Tablets USP (XL) 150 mg and 300 mg (once-daily) as an antidepressant in the market.